STND Stock
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
STND — AI-powered stock analysis, price $33.00, MoonshotScore 49/100.
Price live · AI analysis from Jul 5, 2026Analyst Coverage for STND: STND does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates STND against Technology peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
STND: the 1 perspectives are evenly split.
How is this calculated? →STND Company Overview
Who Are STND's Competitors?
STND is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| SNDX Syndax Pharmaceuticals, Inc. | $22.11 | +1.33% | $1.96B | 79 |
| ANAB AnaptysBio, Inc. | $63.69 | +0.43% | $2.75B | 79 |
| CGEN Compugen Ltd. | $2.37 | +3.73% | $223.62M | 76 |
| XFOR X4 Pharmaceuticals, Inc. | $4.09 | -0.86% | $386.20M | 76 |
| DAWN Day One Biopharmaceuticals, Inc. | $21.53 | +0.00% | $2.22B | 68 |
| GLUE Monte Rosa Therapeutics, Inc. | $23.06 | -4.75% | $1.50B | 68 |
| RNAM Avidity Biosciences Inc | $72.86 | +0.05% | $11.26B | 68 |
| ZLDPF Zealand Pharma A/S | $45.61 | -2.85% | $3.23B | 68 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
STND (STND) Valuation Context
Relative to its peer group, STND's quantitative score of 49/100 is below the peer average of 76/100.
ROE 5%Key Financial Metrics
Return on equity for STND stands at 4.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 22.5%, showing how much profit it generates from its asset base. A current ratio of 0.00 means current liabilities exceed short-term assets, a liquidity point worth watching.
STND Financials
Bull Case vs Bear Case
Bull Case
- Recent insider buying suggests confidence in STND's future, which can indicate strong belief in company fundamentals.
- Community sentiment has shifted positively, with discussions highlighting innovative projects and potential growth.
- Analysts are noting STND's strategic partnerships that could enhance market reach and operational efficiency.
- The overall market perception has improved, with STND being recognized for its resilience in a competitive landscape.
Bear Case
- Some community members express concern over STND's recent product performance, indicating potential challenges ahead.
- Insider selling has raised eyebrows, leading to speculation about management's confidence in upcoming results.
- Market sentiment remains cautious due to broader economic uncertainties that could impact STND's growth trajectory.
- Recent news coverage has highlighted competitive pressures, suggesting STND may struggle to maintain its market position.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
STND Latest News
No recent news available for STND.
STND Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for STND.
Price Targets
Wall Street price target analysis for STND.
STND MoonshotScore
What does this score mean?
The MoonshotScore rates STND's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
STND Stock: Key Questions Answered
What are the key factors to evaluate for STND?
Evaluate STND on fundamentals, analyst consensus, and risk factors. Not financial advice.
How frequently does STND data refresh on this page?
STND prices update in real time during U.S. market hours. Fundamentals refresh after quarterly filings; analyst ratings and AI insights update daily; news is aggregated continuously.
What has driven STND's recent stock price performance?
STND moves on earnings results, analyst revisions, sector rotation, and market sentiment. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider STND overvalued or undervalued right now?
Valuing STND requires multiple metrics. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
What research should beginners do before buying STND?
Before investing in STND, research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Why might investors consider adding STND to a portfolio?
The case for STND depends on individual goals and risk tolerance. Weigh rewards against risks and diversify. Not financial advice.
Can I buy fractional shares of STND?
Yes, most major brokerages offer fractional shares of STND with no minimum purchase requirement. This means you can invest any dollar amount regardless of the share price. Check your brokerage platform for specific terms, fees, and fractional share availability.
How can I track STND's earnings and financial reports?
STND reports quarterly earnings approximately 4-6 weeks after each fiscal quarter ends. You can track earnings dates, revenue and EPS estimates, and actual results on this page's Financials tab. Earnings surprises (beats or misses) often cause significant short-term price moves. Setting up alerts through your brokerage for STND earnings announcements is recommended.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.